ScholarIQanswers from OpenAlex

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening

PaperCitations, authors & open-access status

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening have?

ScholarIQcitation count

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening has 16 citations in the OpenAlex counts ScholarIQ stores.

When was Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening published?

ScholarIQyear

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening has 2024 year in the ScholarIQ index.

What is the open-access status of Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening?

ScholarIQoa status

Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening has gold oa status in the ScholarIQ index.

What is the DOI of Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening?

ScholarIQdoi

The DOI for Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening is on the source record.

What is the PMID of Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening?

ScholarIQpmid

The PMID for Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening is on the source record.

What is the OpenAlex record for Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening?

ScholarIQopenalex

The OpenAlex for Downregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial